SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-18-005177
Filing Date
2018-03-21
Accepted
2018-03-21 17:07:32
Documents
93
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nby20171231_10k.htm 10-K 2439376
2 EXHIBIT 3.1 ex_107885.htm EX-3.1 32390
3 EXHIBIT 23.1 ex_107886.htm EX-23.1 3167
4 EXHIBIT 31.1 ex_107887.htm EX-31.1 9320
5 EXHIBIT 31.2 ex_107888.htm EX-31.2 9754
6 EXHIBIT 32.1 ex_107889.htm EX-32.1 4742
7 EXHIBIT 32.2 ex_107890.htm EX-32.2 5010
14 nby20171231_10kimg001.gif GRAPHIC 16801
  Complete submission text file 0001437749-18-005177.txt   11017122

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nby-20171231.xml EX-101.INS 2357422
9 XBRL TAXONOMY EXTENSION SCHEMA nby-20171231.xsd EX-101.SCH 103247
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20171231_cal.xml EX-101.CAL 51710
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20171231_def.xml EX-101.DEF 686522
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20171231_lab.xml EX-101.LAB 567721
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20171231_pre.xml EX-101.PRE 716018
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 18705088
SIC: 2834 Pharmaceutical Preparations